Insider Selling: Exponent, Inc. (NASDAQ:EXPO) Director Sells 7,000 Shares of Stock

Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $103.83, for a total value of $726,810.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at approximately $8,383,441.86. This represents a 7.98 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Exponent Trading Down 1.2 %

NASDAQ EXPO opened at $97.40 on Friday. The stock has a market capitalization of $4.94 billion, a price-to-earnings ratio of 47.05 and a beta of 0.69. The stock has a 50-day moving average of $107.23 and a 200 day moving average of $101.97. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75.

Exponent Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 20th. Stockholders of record on Friday, December 6th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Friday, December 6th. Exponent’s payout ratio is 54.11%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. raised its position in Exponent by 5.8% during the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after acquiring an additional 291,047 shares during the period. Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Exponent by 6.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after purchasing an additional 284,179 shares in the last quarter. Conestoga Capital Advisors LLC raised its position in shares of Exponent by 1.6% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock worth $323,535,000 after purchasing an additional 43,257 shares during the last quarter. State Street Corp raised its position in shares of Exponent by 0.7% during the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock worth $212,151,000 after purchasing an additional 13,644 shares during the last quarter. Finally, Geneva Capital Management LLC lifted its stake in Exponent by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after buying an additional 27,339 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Analyst Ratings Changes

Separately, Truist Financial reiterated a “buy” rating and issued a $120.00 target price (up from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.